Skip to main content

Nasdaq Markets

Could Auto Loans Be Problematic for Banks Down the Line?

6 years 2 months ago
The coronavirus pandemic has likely resulted in hundreds of billions of dollars in total loan deferrals, in which lenders allow borrowers to skip certain payments and move them to the end of a deferment period or perhaps the end of the loan term. These deferrals have become a bi

United Airlines Adds Florida Flights in Bid to Lose Less Money

6 years 2 months ago
More than five months into the COVID-19 pandemic in the U.S., air travel demand remains stuck at a fraction of 2019 levels. That's a big problem for airlines and their employees. The short-term payroll support program implemented in late March -- under which the federal governme

Better Buy: Beyond Meat vs. Chipotle

6 years 2 months ago
Chipotle Mexican Grill (NYSE: CMG) and Beyond Meat (NASDAQ: BYND) are as close as you can probably get to companies that have their own mantras. Chipotle's been waving the "food with integrity" banner for ages. Dive into the first line of Beyond Meat's mission statement, meanwhi

The 1 Stock I'd Buy Right Now

6 years 2 months ago
Latin America has almost twice the population of the U.S., and 25% more internet users, but it's way behind in e-commerce adoption. In 2019, the region's online spending was only 4.4% of total retail sales versus 10.9% for the U.S., even though both geographies have around 200

Better Coronavirus Stock: AstraZeneca vs. Regeneron

6 years 2 months ago
Any shortlist of leaders in the race to develop a coronavirus vaccine will definitely include AstraZeneca (NYSE: AZN). And Regeneron Pharmaceuticals (NASDAQ: REGN) will certainly rank highly on any list of the top companies developing potential treatments for COVID-19.

3 Millennial-Focused Stocks Poised for a Bull Run

6 years 2 months ago
Data from Pew Research suggests that millennials overtook baby boomers in 2019 as the largest age demographic in the U.S., and people within this increasingly influential generation are just beginning to enter their prime spending years. With the rise of Robinhood and other app-

Better Buy: Enbridge vs. Enterprise Products Partners

6 years 2 months ago
The energy sector is deeply out of favor, as oil and natural gas companies pull back in the face of depressed oil prices. But the different parts of the industry aren't impacted equally. Midstream players like Canada's Enbridge (NYSE: ENB) and U.S.-domiciled Enterprise Products

Is Inovio Pharmaceuticals a Good Coronavirus Stock to Buy?

6 years 2 months ago
There have been more than 20 million coronavirus cases and 749,000 COVID-19-related deaths worldwide. The U.S. alone has recorded 5 million cases and 169,000 related deaths. Before life, and the economy, can return to normal, a safe and effective vaccine must be made widely avai

Is Carnival Stock a Buy?

6 years 2 months ago
With the breakout of the COVID-19 pandemic earlier this year, the cruise industry is facing a historically tough challenge. As numerous countries imposed lockdowns and closed borders, cruise companies joined airlines in grounding their fleets as cancellations mounted with alarmi

3 Stocks Robinhood Investors Love

6 years 2 months ago
Robinhood, a free app offering commission-free trading of stocks, options, and more, has attracted a lot of attention in recent months. Many investors who use it seem drawn to specific names, and they're not necessarily stocks that receive a lot of coverage.

3 Top Tech Stocks to Buy if the Market Crashes

6 years 2 months ago
The stock market experienced one of its steepest declines less than five months ago. Many stocks have since recovered and are putting up impressive gains, but there's no guarantee that this recent rally will continue. The U.S. unemployment rate is still above 10%, state and loca

Is Gilead Sciences Stock a Buy?

6 years 2 months ago
Gilead Sciences (NASDAQ: GILD) has been at the forefront of the coronavirus treatment space since the early days of the pandemic. During this past spring and early summer, the company donated almost a million doses of its antiviral medication, remdesivir, to the U.S. government

Better Cannabis Stock: Aurora Cannabis or Canopy Growth?

6 years 2 months ago
Aurora Cannabis (NYSE: ACB) and Canopy Growth (NYSE: CGC) are two of the bigger names in the cannabis industry. They're both facing similar challenges -- namely, how to keep growing amid rising competition while also getting closer to breakeven. Within the past 14 months, bot

The 3 Biggest Near-Term Risks That Inovio Faces

6 years 2 months ago
Inovio Pharmaceuticals (NASDAQ: INO) has enjoyed a remarkable year so far by any standard. The biotech is in the thick of the race to develop a COVID-19 vaccine. It has made significant progress with its other pipeline candidates. Inovio's shares have skyrocketed close to 350%.
Checked
23 minutes 30 seconds ago
This feed is responsible for generating the rss feed related to the topic Markets
Subscribe to Nasdaq Markets feed